DUBLIN--(BUSINESS WIRE)--The "Pompe Disease Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024" report has been added to ResearchAndMarkets.com's offering.
The report predicts the global pompe disease market to grow with a CAGR of 8.4% over the forecast period of 2018-2024.
The report on global pompe disease market provides qualitative and quantitative analysis for the period of 2016 to 2024. The study covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific and RoW for the period of 2016 to 2024.
Increasing developments in the gene therapy and enzyme replacement therapies are the primary factors driving the growth of Pompe disease Market. However, inflated costs associated with the pompe disease therapy could hinder the market growth opportunities. Moreover, research activities performed to find an effective treatment for the disease and the growth in the special regulatory drug designations for orphan drugs can further create the growth opportunities for pompe disease market
Among the geographies, North America held the largest market share in 2017 and is expected to hold its dominance in pompe disease market over the forecast period. Asia Pacific is expected to grow at the highest CAGR over the forecast period, owing to increasing awareness about the pompe disease & its treatment procedure and rising healthcare infrastructure in Asia Pacific countries.
Global Pompe Disease Market by Therapy Type
- Enzyme Replacement Therapy
- Substrate Reduction Therapy
Global Pompe Disease Market by Molecule Type
- Small Molecules
Global Pompe Disease Market by Dosage Form
Global Pompe Disease Market by Route of Administration
- Amicus Therapeutics
- Biomarin Pharmaceuticals
- Audentes Therapeutics
- Valerion Therapeutics
For more information about this report visit https://www.researchandmarkets.com/research/47s36x/global_pompe?w=4